A recent study, published in Cell, suggests a systemically given small molecule could revive neural circuits in mice with spinal cord injury, restoring their ability to walk. The research, which was carried out at Boston Children’s Hospital (MA, USA), could complement regenerative therapies, aiding those with paralysis caused by spinal cord injury.
You may also be interested in...
Cell therapy weekly: New scarring model identifies anti-fibrosis drug
Editor’s picks: World Stem Cell Summit 2020 and Phacilitate Leaders World